Evidence map›Paper›PMID 36943539›Full record

ArticleInflammopharmacology2023

Isostearic acid is an active component of imiquimod formulations used to induce psoriaform disease models.

Simon Straß, Johanna Geiger, Mariella Martorelli, Sophia Geiger, Natascha Cloos, Manuel Keppler, Tina Fischer, Laura Riexinger, Anna Schwamborn, Jamil Guezguez and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammopharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Dissecting the role of imiquimod and isostearic acid in Aldara-induced psoriasis mouse model.JID innovations : skin science from molecules to population health · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Simon StraßPharmaceutical Chemistry, Institute for Pharmaceutical Sciences, Eberhard Karls University Tübingen, Tübingen, Germany.
Johanna GeigerSynovo GmbH, Tübingen, Germany.
Mariella MartorelliPharmaceutical Chemistry, Institute for Pharmaceutical Sciences, Eberhard Karls University Tübingen, Tübingen, Germany.
Sophia GeigerSynovo GmbH, Tübingen, Germany.
Natascha CloosSynovo GmbH, Tübingen, Germany.
Manuel KepplerSynovo GmbH, Tübingen, Germany.
Tina FischerSynovo GmbH, Tübingen, Germany.
Laura RiexingerSynovo GmbH, Tübingen, Germany.
Anna SchwambornSynovo GmbH, Tübingen, Germany.
Jamil GuezguezSynovo GmbH, Tübingen, Germany.
Nadja SpäthSynovo GmbH, Tübingen, Germany.
Santiago CrucesSynovo GmbH, Tübingen, Germany.
Jan-Hinrich GuseSynovo GmbH, Tübingen, Germany.
Thaisa Lucas SandriSynovo GmbH, Tübingen, Germany.
Michael BurnetSynovo GmbH, Tübingen, Germany. michael.burnet@synovo.com.ORCID http://orcid.org/0000-0003-4311-5441
Stefan LauferPharmaceutical Chemistry, Institute for Pharmaceutical Sciences, Eberhard Karls University Tübingen, Tübingen, Germany.
Synovo (Germany) · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Topical imiquimod based creams are indicated as immune stimulants for papillomas and various skin neoplasms. Imiquimod is considered a TLR7 ligand. These creams are also used in research to induce skin inflammation in mice as a model for psoriasis. We observed that this inflammatory response was not strictly imiquimod dependent and we set out to establish which components drive the proinflammatory effects. To this end, we examined the induction response in a BALB/cJRj mouse model, in which 50 mg of cream is applied to 2 cm

Indexed as

DermatitisToll-Like Receptor 7AnimalsCytokinesDisease Models, AnimalImiquimodInflammationMiceMice, Inbred BALB CSkinStearic AcidsCytokinesImiquimodisostearic acidStearic AcidsToll-Like Receptor 7DermatitisImiquimodIsostearic acidPsoriasis

Identifiers

PMID36943539
OpenAlexW4328049657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.